Effect of hypertension on anticoagulated patients with atrial fibrillation

Aim To test the hypothesis that stroke and systemic embolic events (SEE) in the Stroke Prevention using an ORal Thrombin Inhibitor in atrial Fibrillation (SPORTIF) III and V trials were related to blood pressure, and that differences in event rates (stroke and SEE, bleeding) could also be related to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2007-03, Vol.28 (6), p.752-759
Hauptverfasser:	Lip, Gregory Y.H., Frison, Lars, Grind, Margaretha
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anticoagulants - therapeutic use Arterial hypertension. Arterial hypotension Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Azetidines - therapeutic use Benzylamines - therapeutic use Biological and medical sciences Blood and lymphatic vessels Cardiac dysrhythmias Cardiology. Vascular system Cross-Sectional Studies Double-Blind Method Female Heart Hemorrhage - etiology Hemorrhage - prevention & control Humans Hypertension - complications Longitudinal Studies Male Medical sciences Middle Aged Neurology Risk Factors Stroke - etiology Stroke - prevention & control Thromboembolism - etiology Thromboembolism - prevention & control Vascular diseases and vascular malformations of the nervous system Warfarin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!